Theralase Technologies Inc.
TLTFF
$0.11
$0.004.46%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.88% | 16.95% | -9.11% | 9.95% | 9.22% |
| Total Depreciation and Amortization | -3.99% | -9.37% | -10.10% | -7.20% | -6.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.51% | 76.07% | 17.37% | 28.95% | -29.84% |
| Change in Net Operating Assets | 113.98% | -149.24% | 1,866.96% | 139.99% | -436.38% |
| Cash from Operations | 50.38% | -149.43% | 70.08% | 64.35% | -126.85% |
| Capital Expenditure | -74.60% | -1,250.00% | -1,566.67% | 41.67% | 22.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -74.60% | -1,250.00% | -1,566.67% | 41.67% | 22.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -24.68% | -27.39% | -29.65% | 8.92% | -7.31% |
| Issuance of Common Stock | -48.78% | 31.54% | -74.37% | -59.50% | 186.70% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -43.04% | 30.26% | -77.81% | -63.25% | 190.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 134.76% | -126.94% | -282.60% | 69.11% | 43.54% |